Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Assess which option is safer for your needs—software or hardware wallets—by weighing security risks, accessibility, and practical safeguards.
21,982 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Standard Chartered is moving to absorb Zodia Custody's crypto operations, extending its digital-asset platform. The d...
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Taxing wealthy harder than it looks sounds simple: just raise rates on big earners. In practice, money moves, lawyers...
Ready to put $3,000 to work? This practical guide shows a straightforward, diversified approach to investing in the b...
High-end home sellers confront new commission options after the NAR decoupled buyer and seller fees. This report expl...
MortgageOne TPO announces an ARIVE integration alongside the Pathway CDFI loan program, aiming to broaden homeownersh...
A dramatic one-day move put Relay Therapeutics in the spotlight. After encouraging Phase 2 results for zovegalisib an...
XRP stalls after a rejection at the 100-day moving average, with price around $1.37 as bulls weigh the next move. Key...
Policy clarity cleared a Senate hurdle, but bitcoin demand weakens despite the CLARITY Act win as ETF buyers pull bac...
As market chatter heats up in 2026, investors are watching whether GE Vernova, MercadoLibre, or NVR will join the gro...
Bitcoin slides through the weekend, hitting a fresh monthly low as risk-off sentiment tightens. Ethereum nears $2,000...